 |
GENEVA, Sept. 6, 2023 /PRNewswire/ -- The first patient has been enrolled in a UK study of large vessel de novo coronary artery disease treated with SELUTION SLR™. This is a trial initiated by physicians at the Wrightington, Wigan and Leigh Teaching Hospitals NHS Foundation Trust, which is where the first patient was enrolled. SELUTION...
A new generation of young Australian small business owners is redefining success, driven by a desire to create a lasting legacy through the positi...
In a world where many small businesses are still trying to work out how to actually use AI (not just talk about it), Australian fintech LoanOption...
The world of mobility is changing fast, and car ownership is no longer the default. Across Australia, professionals and businesses alike are seeki...
“You shouldn’t need a large account balance to experience real-time investing. Technology should make that kind of access universal.” For decades...
Thryv® (NASDAQ: THRY), Australia’s provider of the leading small business marketing and sales software platform, announced that Greg Nicolle, G...
pay.com.au, the end-to-end payments and rewards platform, today announced the launch of International Payments, Australia’s first foreign exchange...